The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
November 16th 2024
Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with diabetes in the BPROAD trial.
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Misunderstandings in Identifying and Treating Hypothyroidism
According to Kathleen “Kittie†Wyne, MD, PhD, The Ohio State University, in the identification and treatment of hypothyroidism, people need to be aware that the symptoms associated with hypothyroidism can be non-specific.
Hypothyroidism: Assessing Rates of Adherence to Levothyroxine
At AACE 2017, Kathleen “Kittie†Wyne, MD, PhD, The Ohio State University, discussed new data on hypothyroidism. Although hypothyroidism requires lifelong adherence to therapy, compliance still remains challenging.
Diabetes: Never Fail to Examine The Foot
According to Andrew Boulton, MD, University of Manchester, UK, University of Miami, Florida, the most important take home message for doctors regarding the diabetic foot and reducing amputations, is to remove their patients’ shoes and socks and look at their feet.
Diabetes Care: The Challenges of Fasting and Feasting
At AACE 2017, Shashank Joshi, MD, Lilavati Hospital and Research Centre, Mumbai explained his team’s simple diabetes treatment formula: A for A1C, B for blood pressure, C for cholesterol (LDL cholesterol), and D for diet that’s culturally sensitive and adaptable.
Ambulatory and Endocrine Functions of the Bone
In terms of specific endocrine functions, bones favor glucose metabolism and homeostasis and are necessary for memory formation and for muscle function during exercise. Gerard Karsenty, MD, PhD also explained that osteo-calcium is not only necessary to foster this function, but it’s also sufficient, and can improve this function in animals.
Diabetes: Transforming Technology into Safe and Effective Medicines
Larry Altstiel, MD, PhD, EVP, Chief Medical Officer, vTv Therapeutics also discussed their team’s programs in type 2 diabetes. One is an activator of an enzyme called glucocynase – a master regulator for glucose in the body. According to Altstiel, when glucose is too high, it either shuns it off to energy production or stores it in the form of glycogen. It’s an insulin independent way of how the body controls glucose.